RADIUM-223. PLACE IN THE TREATMENT OF METASTATIC CASTRATION-REFRACTORY PROSTATE CANCER

Patients with castration-refractory prostate cancer (PC) are a complicated group of patients for treatment. At the time of diagnosis, 85% of patients have a localized tumor process, however, in 40% of patients, generalization of the tumor process is observed. The most common localization of prostate...

全面介紹

書目詳細資料

發表在:	Исследования и практика в медицине
Main Authors:	A. A. Kostin, A. G. Muradyan, A. O. Tolkachev, S. V. Popov
格式:	Article
語言:	俄语
出版:	QUASAR, LLC 2017-12-01
主題:	prostate cancer pc castration-refractory mcrpc radium-223 ksofigo hormoneresistence
在線閱讀:	https://www.rpmj.ru/rpmj/article/view/223